Aponermin or placebo in combination with thalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (CPT-MM301): a randomised, double-blinded, placebo-controlled, phase 3 trial.

Autor: Xia, Zhongjun1 (AUTHOR), Leng, Yun2 (AUTHOR), Fang, Baijun3 (AUTHOR), Liang, Yang1 (AUTHOR), Li, Wei4 (AUTHOR), Fu, Chengcheng5 (AUTHOR), Yang, Linhua6 (AUTHOR), Ke, Xiaoyan7 (AUTHOR), Jiang, Hua8 (AUTHOR), Weng, Jianyu9 (AUTHOR), Liu, Li10 (AUTHOR), Zhao, Yaozhong11 (AUTHOR), Zhang, Xuejun12 (AUTHOR), Huang, Zhongxia2 (AUTHOR), Liu, Aichun13 (AUTHOR), Shi, Qingzhi14 (AUTHOR), Gao, Yuhuan15 (AUTHOR), Chen, Xiequn16 (AUTHOR), Pan, Ling17 (AUTHOR), Cai, Zhen18 (AUTHOR)
Zdroj: BMC Cancer. 10/14/2023, Vol. 23 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje